AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 258: R32-R38, 1990;
0363-6119/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardiner, S. M.
Right arrow Articles by Bloom, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardiner, S. M.
Right arrow Articles by Bloom, S. R.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 258, Issue 1 32-R38, Copyright © 1990 by American Physiological Society

ARTICLES

Regional hemodynamic effects of neuromedin U in conscious rats

S. M. Gardiner, A. M. Compton, T. Bennett, J. Domin and S. R. Bloom
Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, United Kingdom.

In conscious unrestrained Long-Evans rats, chronically instrumented with miniaturized pulsed Doppler flow probes, intravenous administration of porcine neuromedin U-8 by bolus (0.1 and 1.0 nmol) or infusion (1 and 10 nmol/h) exerted potent constrictor effects on the superior mesenteric vascular bed. With the choice of an appropriate dose, the reduction in superior mesenteric blood flow was not accompanied by any changes in systemic arterial blood pressure, heart rate, and renal or hindquarters blood flows. Porcine neuromedin U-25 had similar effects to neuromedin U-8, but was generally more potent. In Brattleboro rats the pattern of response to neuromedin U-25 was similar to that seen in Long-Evans rats, indicating that mesenteric vasoconstriction was not dependent on release of endogenous vasopressin. In Long-Evans rats the regional hemodynamic actions of rat neuromedin U were comparable with those of porcine neuromedin U-25. The latter peptide at a dose of 1.0 nmol caused a rise in total peripheral resistance and a reduction in cardiac output, with an inconsistent change in heart rate. The results raise the possibility that the high concentration of neuromedin U in the rat intestine is associated with the control of local blood flow.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
P. J. Brighton, A. Wise, N. B. Dass, and G. B. Willars
Paradoxical Behavior of Neuromedin U in Isolated Smooth Muscle Cells and Intact Tissue
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 154 - 164.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. S. Mondal, Y. Date, N. Murakami, K. Toshinai, T. Shimbara, K. Kangawa, and M. Nakazato
Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system
Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G963 - G969.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. D. Westfall, G. P. McCafferty, M. Pullen, S. Gruver, A. C. Sulpizio, V. N. Aiyar, J. Disa, L. C. Contino, I. J. Mannan, and J. P. Hieble
Characterization of Neuromedin U Effects in Canine Smooth Muscle
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 987 - 992.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. A. Hedrick, K. Morse, L. Shan, X. Qiao, L. Pang, S. Wang, T. Laz, E. L. Gustafson, M. Bayne, and F. J. Monsma Jr.
Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
Mol. Pharmacol., October 1, 2000; 58(4): 870 - 875.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
A. L. Salmon, A. H. Johnsen, M. Bienert, G. McMurray, K. A. Nandha, S. R. Bloom, and C. Shaw
Isolation, Structural Characterization, and Bioactivity of a Novel Neuromedin U Analog from the Defensive Skin Secretion of the Australasian Tree Frog, Litoria caerulea
J. Biol. Chem., February 18, 2000; 275(7): 4549 - 4554.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. G. Szekeres, A. I. Muir, L. D. Spinage, J. E. Miller, S. I. Butler, A. Smith, G. I. Rennie, P. R. Murdock, L. R. Fitzgerald, H.-l. Wu, et al.
Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3
J. Biol. Chem., June 30, 2000; 275(27): 20247 - 20250.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Shan, X. Qiao, J. H. Crona, J. Behan, S. Wang, T. Laz, M. Bayne, E. L. Gustafson, F. J. Monsma Jr., and J. A. Hedrick
Identification of a Novel Neuromedin U Receptor Subtype Expressed in the Central Nervous System
J. Biol. Chem., December 8, 2000; 275(50): 39482 - 39486.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Raddatz, A. E. Wilson, R. Artymyshyn, J. A. Bonini, B. Borowsky, L. W. Boteju, S. Zhou, E. V. Kouranova, R. Nagorny, M. S. Guevarra, et al.
Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System
J. Biol. Chem., October 13, 2000; 275(42): 32452 - 32459.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online